Analyst firms · Morgan Stanley · DOCS

Morgan Stanley DOCS price target and rating history

Doximity Inc. (DOCS) · Technology

Morgan Stanley rates Doximity Inc. (DOCS) Overweight with a $65 price target, as of its latest action on Dec 15, 2025. It has published 8 rating actions on DOCS since July 2021, including 2 upgrades and 1 downgrade. Across 12 firms with a DOCS price target in the last 12 months, the median target is $27. Morgan Stanley's $65 is 141% above that.

Current rating

Overweight

Price target

$65

Median target, all firms

$27

Actions on DOCS

8

Morgan Stanley price target on DOCS

Every Morgan Stanley rating on DOCS

• Dec 15, 2025
  UpgradeMorgan Stanley upgrades to Overweight from Equal-Weight, price target $65
• Nov 14, 2024
  UpgradeMorgan Stanley upgrades to Equal-Weight from Underweight, price target $33 to $53
• Jan 6, 2023
  DowngradeMorgan Stanley downgrades to Underweight from Equal-Weight, price target $32 to $29
• May 18, 2022
  ReiterateMorgan Stanley cuts its price target to $35 from $55, keeps Equal-Weight
• Dec 17, 2021
  ReiterateMorgan Stanley cuts its price target to $58 from $72, keeps Equal-Weight
• Nov 10, 2021
  ReiterateMorgan Stanley raises its price target to $72 from $71, keeps Equal-Weight
• Aug 31, 2021
  ReiterateMorgan Stanley raises its price target to $71 from $52, keeps Equal-Weight
• Jul 19, 2021
  InitiateMorgan Stanley starts coverage at Equal-Weight, price target $52

How other firms rate DOCS

Each firm's latest rating and stated target in the last 12 months.

Questions about Morgan Stanley and DOCS

What is Morgan Stanley's price target for DOCS?

Morgan Stanley's latest stated price target for Doximity Inc. (DOCS) is $65, from its action on Dec 15, 2025.

What is Morgan Stanley's rating on DOCS?

Morgan Stanley rates DOCS Overweight, a bullish rating, as of Dec 15, 2025.

When did Morgan Stanley last change its view on DOCS?

On Dec 15, 2025, Morgan Stanley upgrades to Overweight from Equal-Weight, price target $65.

How does Morgan Stanley's DOCS target compare with other analysts?

Across 12 firms with a DOCS price target in the last 12 months, the median target is $27. Morgan Stanley's $65 is 141% above that.

More DOCS rating histories

• Wells Fargo7
• BofA Securities6
• Barclays4
• KeyBanc Capital Markets3
• Robert W. Baird3
• BTIG3
• Jefferies3
• Truist Securities3
• Evercore ISI3
• Canaccord Genuity4
• Raymond James5
• Goldman Sachs6
• Piper Sandler4
• Leerink Partners4
• Needham6
• J.P. Morgan4
• Guggenheim3

All Morgan Stanley ratingsDOCS news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.